Author(s): Nensi Raytthatha, Isha Shah, Jigar Vyas, Umesh Upadhyay

Email(s): drjigarvyas@gmail.com , ishashah3498@gmail.com

DOI: 10.52711/0975-4377.2021.00043   

Address: Nensi Raytthatha, Isha Shah, Dr. Jigar Vyas, Dr Umesh Upadhyay
Sigma Institute of Pharmacy, Ajwa-Nimeta Road, Waghodia, Baroda, Gujarat, 390019 India.
*Corresponding Author

Published In:   Volume - 13,      Issue - 3,     Year - 2021


ABSTRACT:
Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, named ‘coronavirus disease 2019’ (COVID-19), which threatens human health and public safety. The disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19), presents flu-like symptoms which can become serious in high-risk individuals. During the early phase of the coronavirus (COVID-19) pandemic, design, development, validation, verification and implementation of diagnostic tests were actively conveyed by a large number of diagnostic test manufacturers. In this Review, we give an outline of the crucial role of diagnostic tests during the first world-wide indication of COVID-19. The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) and its associated coronavirus (COVID-19) pandemic has demanded rapid up scaling of in-vitro diagnostic assays to enable mass screening and testing of high-risk groups. To encounter the exponential demand in testing, there has been an expedite development of both molecular and serological assays across a superfluity of manifestos. The adjacent review discusses the current information on these modalities, including nucleic acid amplification tests, direct viral antigen tests. In the analytic stage, real-time reverse transcription-PCR (RT-PCR) assays remain the molecular test of choice for the etiologic diagnosis of SARS-CoV-2.


Cite this article:
Nensi Raytthatha, Isha Shah, Jigar Vyas, Umesh Upadhyay. An Informative Review on screening of COVID-19 (SARS-COVID-II). Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(3):259-5. doi: 10.52711/0975-4377.2021.00043

Cite(Electronic):
Nensi Raytthatha, Isha Shah, Jigar Vyas, Umesh Upadhyay. An Informative Review on screening of COVID-19 (SARS-COVID-II). Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(3):259-5. doi: 10.52711/0975-4377.2021.00043   Available on: https://rjpdft.com/AbstractView.aspx?PID=2021-13-3-14


REFERENCES:
1.    Merriam-Webster, Definition of Coronavirus by Merriam-Webster, Archived from the original on 2020.
2.    Cherry, James; Demmler-Harrison, Gail J, et al, Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Elsevier Health Sciences.
3.    Almeida JD, Berry DM, Cunningham CH, Hamre D. Virology, Coronaviruses Nature.
4.    Murphy A, and Bell D.J, et al. COVID-19, Radiopedia.
5.    Shereen M.A, Khan S, COVID-19 infection: origin, transmission, and characteristics of human coronaviruses, Journal of Advanced Research, Archived from 2020.
6.    Gray R, Covid-19: How long does the coronavirus last on surfaces Archived from 2020.
7.    Neuman, Benjamin W.; Kiss, Gabriella; Kunding, Andreas H.; Bhella, et al, A structural analysis of M protein in coronavirus assembly and morphology. Journal of Structural Biology. 174 (1): 11–22.
8.    Tett SE, Clinical pharmacokinetics of slow-acting antirheumatic drugs, Clinical Pharmacokinetics, 1993; 25(5): 392-407.
9.    https://www.aurorabiomed.com/covid-19-igm-igg-antibody-rapid-test-kit/,access on 9 January 2020
10.    RNA Extraction. AssayGenie, Retrieved 7 May 2020
11.    How is the COVID-19 Virus Detected using Real Time RT-PCR? IAEA, 2020.
12.    Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis, Clinical Science, 2005.
13.    Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) on 2020.
14.    Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments". Clinical Chemistry. 55 (4): 61122.
15.    Dinnes J, Deeks JJ, Adriano A, Berhane S, Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection, Cochrane Database of Systematic Reviews.
16.    Xu R, Cui B, Duan X, Zhang, et al, Saliva: potential diagnostic value and transmission of 2019-nCoV, International Journal of Oral Science.
17.    Dinnes J, Deeks JJ, Adriano A, Berhane S, Infection, Cochrane Database of Systematic Reviews.
18.    World Health Organization. Clinical management of COVID-19 (Interim Guidance) World Health Organization 2020, 2020.
19.    Abbasi J, the Promise and Peril of Antibody Testing for COVID-19, JAMA. 323 (19): 1881–83.
20.    Dinnes J, Deeks JJ, Adriano A, Berhane S, Infection, Cochrane Database of Systematic Reviews.
21.    Serology-based tests for COVID-19. Johns Hopkins Center for Health Security, accessed on 2020.
22.    Developing Antibodies and Antigens for COVID-19 Diagnostics, Technology Networks, 2020.
23.    83. Guglielmi G, Fast coronavirus tests: what they can and can't do, Nature (journal).585(7826), 496–498
24.    Piras A, Rizzo D, Uzzau S, De Riu G, Rubino S, Bussu F. Inappropriate nasopharyngeal sampling for SARS-CoV-2 detection is a relevant cause of false-negative reports. Otolaryngol Head Neck Surg, 2020.
25.    Pasomsub E, Watcharananan SP, Boonyawat K, et al, Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Clin Microbiol Infect, 2020.
26.    Lin C, Xiang J, Yan M, Li H, Huang S, Shen Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19) Clin Chem Lab Med. 2020.
27.    Wang W, Xu Y, Gao R, Lu R, Han K, Wu Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020.
28.    Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol, 2020.
29.    Wolfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Muller MA. Virological assessment of hospitalized patients with COVID-2019, Nature. 2020; 581: 465–469.
30.    Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients, Clin Infect Dis, 2020.
31.    Clinical management protocol: covid-19: Government of India Ministry of Health and Family Welfare Directorate General of Health Services (EMR Division) Version 5 03.07.20.

Recomonded Articles:

Author(s): Deepak Prashar*

DOI:         Access: Open Access Read More

Author(s): Shivom, Shambaditya Goswami, Nikita Pal, Ravindra Pal Singh, Asheesh Singh, M V Kumudhavalli

DOI: 10.5958/0975-4377.2020.00038.5         Access: Open Access Read More

Author(s): Isha Shah, Nensi Raytthatha, Jigar Vyas, Umesh Upadhyay

DOI: 10.52711/0975-4377.2021.00039         Access: Closed Access Read More

Author(s): Nensi Raytthatha, Isha Shah, Jigar Vyas, Umesh Upadhyay

DOI: 10.52711/0975-4377.2021.00043         Access: Closed Access Read More

Research Journal of Pharmaceutical Dosage Forms and Technology (RJPDFT) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. ...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/0975-4377 


Recent Articles




Tags